Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Neuralstem (CUR +9.5%) trades up after saying it will provide an update on the Phase I...

  • Thursday, October 4, 2012, 1:15 PM ET
    Neuralstem (CUR +9.5%) trades up after saying it will provide an update on the Phase I Neuralstem ALS trial of its human spinal cord stem cells, NSI-566, in the treatment of Lou Gehrig's disease. The update will be given by its principal investigator at the American Neurological Association annual meeting on Monday, October 8, 2012.
Track new comments on this story

This news story has 1 comment:

  •  
    MMMM, will it go up from here into conference call
    4 Oct 2012, 04:23 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »